Cargando…
A retrospective approach to evaluating potential adverse outcomes associated with delay of procedures for cardiovascular and cancer-related diagnoses in the context of COVID-19
OBJECTIVE: During the COVID-19 pandemic, health systems postponed non-essential medical procedures to accommodate surge of critically-ill patients. The long-term consequences of delaying procedures in response to COVID-19 remains unknown. We developed a high-throughput approach to understand the imp...
Autores principales: | Zheng, Neil S., Warner, Jeremy L., Osterman, Travis J., Wells, Quinn S., Shu, Xiao-Ou, Deppen, Stephen A., Karp, Seth J., Dwyer, Shon, Feng, QiPing, Cox, Nancy J., Peterson, Josh F., Stein, C. Michael, Roden, Dan M., Johnson, Kevin B., Wei, Wei-Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728428/ https://www.ncbi.nlm.nih.gov/pubmed/33309899 http://dx.doi.org/10.1016/j.jbi.2020.103657 |
Ejemplares similares
-
Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer’s Disease in Real-World Clinical Datasets
por: Wei, Wei-Qi, et al.
Publicado: (2023) -
PheMap: a multi-resource knowledge base for high-throughput phenotyping within electronic health records
por: Zheng, Neil S, et al.
Publicado: (2020) -
Evaluating phecodes, clinical classification software, and ICD-9-CM codes for phenome-wide association studies in the electronic health record
por: Wei, Wei-Qi, et al.
Publicado: (2017) -
Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension
por: Wu, Patrick, et al.
Publicado: (2022) -
High-throughput framework for genetic analyses of adverse drug reactions using electronic health records
por: Zheng, Neil S., et al.
Publicado: (2021)